Moderna، Merck Fall پس از نشت داده های ملانوما

Moderna, Merck Fall After Melanoma Data Leak

Moderna and Merck shares plummeted after data on the companies' personalized melanoma vaccine wasn't enough to prove to investors that a new era of cancer treatments has arrived. Michelle Fay Cortez has more on "Bloomberg The Close." (Source: Bloomberg)